Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Karsten

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Journal of Neuroinflammation|January 19, 2020
Pre-treatment with the viral Toll-like receptor 3 agonist poly(I:C) modulates innate immunity and protects neutropenic mice infected intracerebrally with Escherichia coliSandra Ribes, Christa Arcilla, Martina Ott, et al.
Journal of Molecular Biology|February 6, 2002
Selection of large diversities of antiidiotypic antibody fragments by phage displaySteffen Goletz, Peter Astrup Christensen, Peter Kristensen, et al.
Neuroscience Letters|July 6, 2010
The viral TLR3 agonist poly(I:C) stimulates phagocytosis and intracellular killing of Escherichia coli by microglial cellsSandra Ribes, Nina Adam, Sandra Ebert, et al.
Neuroreport|April 18, 2008
Thrombin regulates CD40 expression in microglial cellsJonathan R Weinstein, Russell E Ettinger, Matthew Zhang, et al.
Journal of Cancer Research and Clinical Oncology|February 11, 2018
Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomasTobias Kratzsch, Susanne Antje Kuhn, Andreas Joedicke, et al.
Onkologie|May 8, 2009
Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodiesDarius Dian, Wolfgang Janni, Christina Kuhn, et al.
Anatomical Record (Hoboken, N.J. : 2007)|September 4, 2009
FK506 protects against various immune responses and secondary degeneration following cerebral ischemiaStephan Brecht, Vicki Waetzig, Ute Hidding, et al.
Histochemistry and Cell Biology|May 13, 2005
Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigenChristian Schindlbeck, Udo Jeschke, Sandra Schulze, et al.
Cancer Immunology, Immunotherapy : CII|February 6, 2013
Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6Philippe Ulsemer, Gemma Henderson, Kawe Toutounian, et al.
International Immunopharmacology|July 19, 2006
Detection, isolation and partial characterization of an immunostimulating glycoprotein from Rhodococcus fasciansGünter Butschak, Uwe Karsten, Ute Schelhaas, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Journal of Neuroinflammation|January 19, 2020
Pre-treatment with the viral Toll-like receptor 3 agonist poly(I:C) modulates innate immunity and protects neutropenic mice infected intracerebrally with Escherichia coliSandra Ribes, Christa Arcilla, Martina Ott, et al.
Journal of Molecular Biology|February 6, 2002
Selection of large diversities of antiidiotypic antibody fragments by phage displaySteffen Goletz, Peter Astrup Christensen, Peter Kristensen, et al.
Neuroscience Letters|July 6, 2010
The viral TLR3 agonist poly(I:C) stimulates phagocytosis and intracellular killing of Escherichia coli by microglial cellsSandra Ribes, Nina Adam, Sandra Ebert, et al.
Neuroreport|April 18, 2008
Thrombin regulates CD40 expression in microglial cellsJonathan R Weinstein, Russell E Ettinger, Matthew Zhang, et al.
Journal of Cancer Research and Clinical Oncology|February 11, 2018
Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomasTobias Kratzsch, Susanne Antje Kuhn, Andreas Joedicke, et al.
Onkologie|May 8, 2009
Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodiesDarius Dian, Wolfgang Janni, Christina Kuhn, et al.
Anatomical Record (Hoboken, N.J. : 2007)|September 4, 2009
FK506 protects against various immune responses and secondary degeneration following cerebral ischemiaStephan Brecht, Vicki Waetzig, Ute Hidding, et al.
Histochemistry and Cell Biology|May 13, 2005
Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigenChristian Schindlbeck, Udo Jeschke, Sandra Schulze, et al.
Cancer Immunology, Immunotherapy : CII|February 6, 2013
Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6Philippe Ulsemer, Gemma Henderson, Kawe Toutounian, et al.
International Immunopharmacology|July 19, 2006
Detection, isolation and partial characterization of an immunostimulating glycoprotein from Rhodococcus fasciansGünter Butschak, Uwe Karsten, Ute Schelhaas, et al.
Pageof 12